Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.48 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.48 |
| ▸ | ERN1 | O75460 | 13/20 | 0.47 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3899644 | 0.91 | ERN1 (0.55) | TRIM24TRIM33ERN1CDK1 | |
| SCHEMBL3902703 | 0.87 | NR1H2 (0.52) | TRIM24TRIM33ERN1CDK1 | |
| SCHEMBL7202277 | 0.83 | MEN1 (0.46) | BCL2MCL1TRIM24TRIM33ALDH1A1 | |
| SCHEMBL11114793 | 0.81 | ERN1 (0.58) | TRIM24TRIM33ERN1 | |
| SCHEMBL16584979 | 0.80 | MAOA (0.47) | ERN1CDK1MAOAMAOB | |
| SCHEMBL7535912 | 0.79 | ALDH1A1 (0.43) | BCL2MCL1ERN1ALDH1A1HPGD | |
| SCHEMBL3968071 | 0.79 | MAOA (0.41) | BCL2MCL1ERN1ALDH1A1HPGD | |
| SCHEMBL25466533 | 0.77 | LMNA (0.40) | BCL2MCL1ALDH1A1HPGDMAOA | |
| SCHEMBL7196389 | 0.77 | BCL2 (0.59) | BCL2MCL1ALDH1A1HPGDMAOA | |
| SCHEMBL6094668 | 0.76 | ERN1 (0.57) | TRIM24TRIM33ERN1CDK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | BCL2 369/4885MCL1 3029/4885TRIM24 4167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.